Estimation of Health-Related Utilities for (177)Lu-DOTATATE in GEP-NET Patients Using Utilities Mapped from EORTC QLQ-C30 to EQ-5D-3L and QLU-C10D Utilities

BACKGROUND: Gastroenteropancreatic neuroendocrine tumours (GEP-NET) are a rare, life-threatening type of cancer. The survival benefit of (177)Lu-DOTATATE has been demonstrated in GEP-NET patients. Health technology assessment bodies require data on health-related utility impacts of treatment. A canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Soare, Ioana-Alexandra, Leeuwenkamp, Oscar, Longworth, Louise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611167/
https://www.ncbi.nlm.nih.gov/pubmed/34260017
http://dx.doi.org/10.1007/s41669-021-00280-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611167/
https://www.ncbi.nlm.nih.gov/pubmed/34260017
http://dx.doi.org/10.1007/s41669-021-00280-9

Ejemplares similares